MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 09-10-2025
Anixa Biosciences Total Liabilities 2011-2026 | ANIX
Annual Total Liabilities Anixa Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.7 M | 2.15 M | 2.21 M | 1.49 M | 692 K | 1.48 M | 1.27 M | 889 K | 4.64 M | 4.28 M | 5.05 M | 8.76 M | 6.85 M | 7.59 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.76 M | 692 K | 3.58 M |
Quarterly Total Liabilities Anixa Biosciences
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.24 M | 2.07 M | 2.7 M | 2.22 M | 1.77 M | 1.77 M | 2.15 M | 1.99 M | 1.69 M | 2 M | 2.21 M | 1.66 M | 1.39 M | - | 1.49 M | - | 1.49 M | 1.17 M | 1.19 M | 1.22 M | 1.1 M | - | 1.48 M | 1.48 M | 1.48 M | - | - | - | - | 8.04 M | 889 K | 2.93 M | 3.66 M | 5.06 M | 4.64 M | 4.64 M | 4.64 M | 5.01 M | 4.28 M | 4.28 M | 4.28 M | - | 5.05 M | 5.05 M | 5.05 M | - | 8.76 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.76 M | 889 K | 3.01 M |
Total Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58.6 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
14.4 M | $ 22.11 | 3.56 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
1.62 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
87.3 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 22.36 | 17.07 % | $ 241 M |  China |
 |
Castle Biosciences
CSTL
|
75.4 M | $ 40.61 | 1.35 % | $ 1.13 B | USA |
 |
Biocept
BIOC
|
22 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
7.26 M | $ 12.13 | -10.01 % | $ 344 M | Israel |
 |
Chembio Diagnostics
CEMI
|
44.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Fulgent Genetics
FLGT
|
90.8 M | $ 28.01 | 7.77 % | $ 847 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.6 | -0.62 % | $ 2.03 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
21.6 M | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
9.31 M | $ 6.03 | 5.79 % | $ 177 M | USA |
 |
DermTech
DMTK
|
64.8 M | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
31.8 B | $ 235.57 | -0.44 % | $ 172 B | USA |
 |
DexCom
DXCM
|
4.2 B | $ 70.1 | 0.3 % | $ 27.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
3.65 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
186 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
4.37 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
427 M | - | 0.12 % | $ 80.1 M | China |
 |
Enzo Biochem
ENZ
|
29.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.7 B | - | - | $ 10.7 B | USA |
 |
Exact Sciences Corporation
EXAS
|
3.53 B | $ 101.63 | -0.02 % | $ 18.8 B | USA |
 |
Mettler-Toledo International
MTD
|
3.37 B | $ 1 470.87 | -0.96 % | $ 31.2 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
326 M | $ 6.63 | 1.69 % | $ 601 M | USA |
 |
CareDx, Inc
CDNA
|
205 M | $ 18.9 | 0.48 % | $ 1.02 B | USA |
 |
Celcuity
CELC
|
130 M | $ 109.17 | 3.95 % | $ 4.31 B | USA |
 |
National Research Corporation
NRC
|
73.5 M | $ 18.9 | -2.07 % | $ 464 M | USA |
 |
Natera
NTRA
|
689 M | $ 254.4 | 2.28 % | $ 25 B | USA |
 |
OPKO Health
OPK
|
835 M | $ 1.36 | 3.03 % | $ 944 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
16.9 B | $ 29.12 | 1.46 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
3.67 M | $ 23.27 | 1.26 % | $ 30.2 M | USA |
 |
Guardant Health
GH
|
1.63 B | $ 109.93 | -2.14 % | $ 13.5 B | USA |
 |
Personalis
PSNL
|
67.3 M | $ 9.35 | 2.19 % | $ 554 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
164 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
20.8 B | $ 244.29 | 1.58 % | $ 44.3 B | USA |
 |
Illumina
ILMN
|
2.7 B | $ 150.14 | 2.01 % | $ 23.9 B | USA |
 |
Charles River Laboratories International
CRL
|
4.02 B | $ 216.77 | 0.31 % | $ 11.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
28.7 B | $ 617.15 | -0.58 % | $ 236 B | USA |
 |
Trinity Biotech plc
TRIB
|
138 M | $ 0.76 | -1.05 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
169 M | $ 36.55 | -0.87 % | $ 2.19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.16 B | $ 178.14 | -1.27 % | $ 19.8 B | USA |
|
Biodesix
BDSX
|
76.4 M | $ 5.96 | -1.16 % | $ 773 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.3 B | $ 253.73 | -2.56 % | $ 21.3 B | USA |
 |
Motus GI Holdings
MOTS
|
4.54 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
7.35 B | $ 202.92 | 0.71 % | $ 16.7 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.7 B | $ 714.55 | 1.09 % | $ 58.9 B | USA |